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ABSTRACT 
The SARS-CoV-2 rapidly spread around the world during 2020, but the precise time in which 
the virus began to spread locally is currently unknown for most countries. Here, we estimate the 
probable onset date of the community spread of SARS-CoV-2 from the cumulative number of 
deaths reported during the early stage of the epidemic in Western Europe and the Americas. Our 
results support that SARS-CoV-2 probably started to spread locally in all western countries 
analyzed between the middle of January and early February 2020, thus long before community 
transmission was officially recognized and control measures were implemented. 
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A novel Betacoronavirus, designated SARS-CoV-2, was identified as the causative agent 
of a severe acute respiratory disease (now known as COVID-19) in Wuhan, Hubei province, 
China, in December 2019.
(1-2)
 In the following weeks, SARS-CoV-2 rapidly spread around the 
world, infecting more than 2 million people and causing more than 135,000 deaths as of April 
15th, 2020.
(3)
 The exponential growth of the COVID-19 pandemic has overloaded hospitals and 
governments’ response measures have disrupted social contacts for >1 billion inhabitants 
worldwide. 
The first infections of SARS-CoV-2 identified in Europe and North America in January 
2020, were related to travelers returning from China.
(4-5)
 Since February 2020, community 
transmission of SARS-CoV-2 was already documented in the USA and multiple European 
countries.
(6)
 However, the precise start time of sustained SARS-CoV-2 local transmission in most 
of these countries is currently unknown. The presence of a substantial fraction of asymptomatic, 
but infectious individuals probably facilitated the undocumented dissemination of the novel 
coronavirus within and among countries before its detection by public health systems.
(7)
 This 
suggests that when domestic infections with SARS-CoV-2 were reported, epidemics were 
probably already growing exponentially in most countries for some time. 
Genomic epidemiology could be a useful tool to track the geographic spread of SARS-
CoV-2 over time and to infer the timing of community transmission. Its implementation has 
enabled to trace back the time of the most recent common ancestor (TMRCA) of SARS-CoV-2 to 
late November 2019,
(8)
 consistent with epidemiological findings that show viral local 
transmission in Wuhan by the middle December 2019.
(9)
 Within this same framework, a recent 
analysis of SARS-CoV-2 genomes from 21 neighborhoods in New York city (NYC) revealed 
that the NYC epidemic has been mainly sourced from untracked transmission between the USA 
and Europe and also pointed that the virus was likely circulating in the city weeks before the first 
confirmed SARS-CoV-2 infection case.
(10)
 At the moment, however, it is challenging to estimate 
the onset date of local transmission clusters within countries (or cities) based solely on genetic 
data. Due to the short period of time since the beginning of the outbreak and to the uneven 
geographic sampling of SARS-CoV-2 genomes, in most cases, there’s still not enough 
phylogenetic signal to define location-specific clusters.
(8,11) 
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Here, we aimed to develop a simple inference method to estimate the onset date of the 
community spread of SARS-CoV-2 in different countries from the cumulative number of 
reported deaths during the early stage of the epidemic. The cumulative number of deaths could 
be a reliable tracker of the SARS-CoV-2 epidemic’s progress within a country.(12) The lack of 
testing and the great proportion of asymptomatic subjects profoundly restrain the capacity of 
most countries to count the true number of SARS-CoV-2 infections, while the smaller number of 
deaths is less prone to such degree of underestimation. Furthermore, the cumulative number of 
reported deaths represents a time-delayed tracker of the SARS-CoV-2 epidemic and thus 
provides valuable information on early epidemic dynamics even when data is obtained after 
implementation of national control measures that reduce the viral spread. Current estimates 
support an infection fatality ratio of SARS-CoV-2 of around 1% and a median time between 
infection and death of around three weeks.
(13-14) 
To infer the probable onset date of the community spread of SARS-CoV-2 in a given 
location, we assumed that: a) as soon as the virus starts spreading locally, the epidemic starts to 
grow exponentially; b) the cumulative number of deaths starts to increase exponentially 20 days 
later than the beginning of the epidemic exponential growth; and c) the rate of exponential 
growth of the number of deaths remains roughly constant during the epidemic early weeks. For 
this study we selected China and those countries from Western Europe (Belgium, France, 
Germany, Italy, Netherlands, Spain, United Kingdom [UK]), North America (New York, USA) 
and South America (Brazil) that were most heavily affected until 5th April 2020.
(3)
 To capture 
the early period of exponential growth of virus transmission, before national control measures 
were implemented, we set the start point to the day when the cumulative number of deaths was 
above one and then counted the cumulative number of deaths during the following three weeks. 
For Brazil, we used the cumulative number of deaths during the first two weeks because first 
social distancing measures were taken before detection of the first death. Then, we estimated the 
number of total infected individuals from the cumulative number of deaths by applying a mean 
infection fatality rate of 1% and a time-delayed from infection to death of 20 days. Finally, we 
plotted the projected number of total infected individuals on a logarithmic scale along time and 
performed a linear regression analysis to estimate the probable onset date of the SARS-CoV-2 
community transmission as the X-intercept point of the analysis. Linear regression analyses were 
performed using Graph Pad v6 (Prism Software, La Jolla, California, USA). 
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The cumulative number of reported deaths has grown exponentially during the selected 
period in all countries analyzed with mean estimated epidemic doubling times ranging from 2.6 
days to 3.8 days, consistent with previous estimations [Supplementary data (Figure 1)].
(15-17)
 
Linear regression analyses of the log number of the projected total infected individuals over time 
resulted in a high coefficient of determination (r
2
 ≥ 0.95) and significant increase (P < 0.0001) 
for all analyzed countries (Figure 1). To validate our approach, we first estimated the beginning 
of community transmission of SARS-CoV-2 in locations with previous molecular clock 
estimates. Using our framework, we traced the onset date of community transmission of SARS-
CoV-2 to early December 2019 in China and to early February 2020 in New York (Figure 1 and 
Table 1). These estimates were consistent with molecular clock calibrations from SARS-CoV-2 
genomic data (Table 1)
(8,10)
, and suggest that both approaches might provide roughly similar 
results. 
We next used our approach to estimate the onset date of local transmission of SARS-
CoV-2 in Western Europe. Our findings suggest that community transmission might have started 
around middle January 2020 in Italy and between late January and early February 2020 in the 
remaining countries (Figure 1). In some countries (Italy and Netherlands) community 
transmission was traced long before (2-4 weeks) the first confirmed SARS-CoV-2 infection case; 
while in others (Spain, France, United Kingdom, Germany, and Belgium) the onset date roughly 
coincides with the time of detection of the first imported cases (Figure 1). In all countries 
analyzed, however, SARS-CoV-2 probably started to spread locally long before community 
transmission was officially recognized and control measures for social distancing and air travel 
restrictions were implemented (Table 1). Of note, our estimation of the onset date of community 
transmission of SARS-CoV-2 in European countries is consistent with the estimated TMRCA of 
some European and European/American clades like the A1a (28
th
 January: 19
th
 January - 17
th
 
February) and the A2a (25
th
 January: 19
th
 January - 2
nd
 February).
(10)
 These results suggest that 
early community transmission of SARS-CoV-2 in Europe could have been fueled by the rapid 
dissemination of few regional clades. 
South America was one of the last geographic regions in the world to declare community 
transmission of SARS-CoV-2. Our study, however, supports that the virus started to spread in 
Brazil at around the early February 2020 (Figure 1), thus coinciding with the epidemic expansion 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 23, 2020. .https://doi.org/10.1101/2020.04.20.20073007doi: medRxiv preprint 
in North America and Western Europe and preceding by more than 20 days the first confirmed 
SARS-CoV-2 infection case in the country (Table 1). According to a recent report of the 
InfoGripe (http://info.gripe.fiocruz.br) - a system of the Fundação Oswaldo Cruz (Fiocruz) that 
weekly monitor the number of hospitalizations of patients who have had symptoms such as 
fever, cough or sore throat and difficulty breathing in Brazil - the number of such cases started to 
increase above levels observed in 2019 since the middle February 2020.
(18)
 More importantly, of 
the retrospective cases that tested positive for some respiratory virus, nine cases were identified 
as SARS-CoV-2 in the eight epidemiological week, between 16th and 22nd February 
(https://covid.saude.gov.br/). These epidemiological data fully agree with our estimation and 
clearly support that SARS-CoV-2 was already circulating in the Brazilian population for some 
weeks before being detected on 26th February 2020. 
Our findings support that, except Italy, SARS-CoV-2 started to spread locally in several 
countries from Western Europe and the Americas at around the same time. Despite this, early 
epidemiological dynamics seem to be quite different across countries. Among those countries 
where SARS-CoV-2 started to spread in late January, Spain passed the milestone of 1,000 deaths 
earlier (20th March) than France (24th March), the UK (27th March), Netherlands (31th March), 
and Germany (3rd April).
(3)
 Similarly, among those regions where SARS-CoV-2 started to 
spread in early February, New York (30th March) and Belgium (2nd April) reached 1,000 deaths 
much earlier than Brazil (10th April).
(3)
 Some studies support that mortality rate might vary 
across regions according to the availability of health-care facilities, underlying demography and 
environmental factors (average temperature, precipitation seasonality and levels of air 
pollution).
(13,19-22)
 Early dynamics in the reported number of deaths may also be influenced by 
the time when local social distancing measures were implemented (Table 1) and by the 
percentage of deaths with laboratory confirmation within each country. 
The narrow confidence intervals of our estimates should be interpreted with caution 
because our method does not account for uncertainty and geographic variability in the mortality 
rate and lag-time between infection and death.
(13-14)
 As more clinical and epidemiological data 
becomes available, it will be possible to refine these estimates by using more accurate 
regionally-specific parameters . Despite this, data from countries that implement wide-scale 
testing for SARS-CoV-2 since the beginning of the outbreak, including people who have mild or 
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no symptoms, supports that the mortality rate will probably not exceed 1% of the total number of 
infected individuals.
(23)
 Hence, the estimates presented here should be closer to the upper limit of 
the likely time range when virus community transmission has started. Another limitation is that 
our method is sensitive to underestimation of the true number of deaths from SARS-CoV-2 and 
should thus be used with caution in countries with limited capacity for testing and/or 
substantially delayed in the report of deaths. 
In summary, our results support that community transmission of SARS-CoV-2 probably 
started in many western countries between middle January to early February 2020, thus long 
before control measures to restrict air travels and promote social distancing were implemented. 
That quite long period of cryptic community transmission (> 4 weeks) in all analyzed countries 
draws attention to the great challenge of tracking the early global spread of SARS-CoV-2 and 
supports that control measures should be adopted at least as soon as first imported cases are 
detected in a new geographic region. This is especially important in the light of studies showing 
that SARS-CoV-2 very likely will enter in a regular circulation after the initial pandemic wave, 
causing recurrent outbreaks in the next years whose frequency and intensity are dependent upon 
virus’ biological features still not well understood, like the duration of immunity that SARS-
CoV-2 can induce.
(24)
 In this scenario, intense virological surveillance is pivotal to early detect 
the virus re-emergence, informing systems of contact tracing and providing evidence to carry out 
appropriate control measures. 
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Table 1. COVID-19 epidemiologic timeline and implementation of related control measures in 
selected countries. 
Country/City 
1st reported 
case 
1st recorded 
death 
Control measures 
Estimated community 
transmission 
Internal 
movement 
International 
travels 
Molecular clock 
(95% HPD) 
This study 
(95% CI) 
China 31-dec-19 09-jan-20 23-jan-20 28-mar-20 
29-nov-19 
(14-nov - 13-dec) 
06-dec-19 
(03-dec - 09-dec) 
New York 01-mar-20 14-mar-20 22-mar-20 02-feb-20 
20-feb-20 
(29-jan - 26-feb) 
06-feb-20 
(04-feb - 08-feb) 
Italy 30-jan-20 21-feb-20 23-fev-20 31-jan-20 - 
15-jan-20 
(14-jan - 16-jan) 
Spain 31-jan-20 13-feb-20 11-mar-20 10-mar-20 - 
28-jan-20 
(26-jan - 29-jan) 
France 24-jan-20 15-feb-20 12-mar-20 17-mar-20 - 
22-jan-20 
(21-jan - 23-jan) 
UK 30-jan-20 05-mar-20 16-mar-20 17-mar-20 - 
29-jan-20 
(27-jan - 31-jan) 
Belgium 02-feb-20 11-mar-20 13-mar-20 17-mar-20 - 
02-feb-20 
(30-jan - 05-feb) 
Germany 27-jan-20 09-mar-20 13-mar-20 16-mar-20 - 
30-jan-20 
(28-jan - 31-jan) 
Netherlands 27-feb-20 06-mar-20 12-mar-20 13-mar-20 - 
29-jan-20 
(27-jan - 30-jan) 
Brazil 26-feb-20 17-mar-20 13-mar-20 17-mar-20 - 
04-feb-20 
(31-jan - 07-feb) 
Source of data is specified on Supplementary Information 
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Figure Legends 
Figure 1. Linear regressions of the log-transformed estimated number of total infections by 
SARS-CoV-2 over time in selected countries. The light blue shadow represents the 95% 
confidence intervals of the log-linear regression line (dark blue) fitted on the estimated number 
of infections (gray dots) for each country as indicated. The goodness of fit (R²), P-value, slope 
and X-intercept for each country are presented for each graph. The date of the 1
st
 reported 
SARS-CoV-2 case in each country is indicated by the gray dashed line. 
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